General developmental health in the VPA-rat model of autism
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Autism is a neurodevelopmental condition diagnosed by impaired social interaction, abnormal communication and, stereotyped behaviors. While post-mortem and imaging studies have provided good insights into the neurobiological symptomology of autism, animal models can be used to study the neuroanatomical, neurophysiological and molecular mediators in more detail and in a more controlled environment. The valproic acid (VPA) rat model is an environmentally triggered model with strong construct and clinical validity. It is based on VPA teratogenicity in humans, where mothers who are medicated with VPA during early pregnancy show an increased risk for giving birth to an autistic child. In rats, early embryonic exposure, around the time of neural tube closure, leads to autism-like anatomical and behavioral abnormalities in the offspring. Considering the increasing use of the VPA rat model, we present our observations of the general health of Wistar dams treated with a single intraperitoneal injection of 500 or, 600 mg/kg VPA on embryonic day E12.5, as well as their male and female offspring, in comparison to saline-exposed controls. We report increased rates of complete fetal reabsorption after both VPA doses. VPA 500 mg/kg showed no effect on dam body weight during pregnancy or, on litter size. Offspring exposed to VPA 500 mg/kg showed smaller brain mass on postnatal days 1 (P1) and 14 (P14), in addition to abnormal nest seeking behavior at P10 in the olfactory discrimination test, relative to controls. We also report increased rates of physical malformations in the offspring, rare occurrences of chromodacryorrhea and, developmentally similar body mass gain. Further documentation of developmental health may guide sub-grouping of individuals in a way to better predict core symptom severity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiology of Pervasive Developmental Disorders
Fombonne, E. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e31819e7203 · Cited by 1,971 · cited 2×
“ORIGINAL RESEARCH ARTICLE published: 24 July 2013 doi: 10.3389/fnbeh.2013.00088 General developmental health in the VPA-rat model of autism”
BackgroundMethodInfluentialAnxiety Disorders in Children and Adolescents with Autistic Spectrum Disorders: A Meta-Analysis
van Steensel, F. J. A., Bögels, S. M., & Perrin, S. (2011) · Clinical Child and Family Psychology Review · doi:10.1007/s10567-011-0097-0 · Cited by 1,463 · cited 1×
“…Stanton et al., 2007; Markram et al., 2008; Bambini-Junior et al., 2011; Kim et al., 2011; Zhang et al., 2012) and commonly found in the autistic spectrum (McAlonan et al., 2002; Gaigg and Bowler, 2007; Perry et al., 2007; Hofvander et al., 2009; MacNeil et al., 2009; van Steensel et al., 2011).”
BackgroundPrenatal Valproate Exposure and Risk of Autism Spectrum Disorders and Childhood Autism
Christensen, J., Grønborg, T. K., Sørensen, M. J., Schendel, D., Parner, E. T., Pedersen, L. H., & Vestergaard, M. (2013) · JAMA · doi:10.1001/jama.2013.2270 · Cited by 1,357
Genetic architectures of psychiatric disorders: the emerging picture and its implications
Sullivan, P. F., Daly, M. J., & O'Donovan, M. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3240 · Cited by 1,177 · cited 2×
“ORIGINAL RESEARCH ARTICLE published: 24 July 2013 doi: 10.3389/fnbeh.2013.00088 General developmental health in the VPA-rat model of autism”
BackgroundMethodInfluentialBehavioral Alterations in Rats Prenatally Exposed to Valproic Acid: Animal Model of Autism
Schneider, T., & Przewłocki, R. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300518 · Cited by 959 · cited 3×
“In utero exposure to VPA between 350–800 mg/kg around E11–12.5 seems to be the critical time window for most autistic-like behavioral and anatomical abnormalities in rats and mice (Ingram et al., 2000; Schneider et al., 2001; Schneider and Przewlocki, 2005; Markram et al., 2008; Kim et al., 2011).”
BackgroundResultInfluentialBetancur, C. (2011) · Brain Research · doi:10.1016/j.brainres.2010.11.078 · Cited by 954
Psychiatric and psychosocial problems in adults with normal-intelligence autism spectrum disorders
Hofvander, B., Delorme, R., Chaste, P., Nydén, A., Wentz, E., Ståhlberg, O., Herbrecht, E., Stopin, A., Anckarsäter, H., Gillberg, C., et al. (2009) · BMC Psychiatry · doi:10.1186/1471-244x-9-35 · Cited by 812
Brain growth across the life span in autism: Age-specific changes in anatomical pathology
Courchesne, E., Campbell, K., & Solso, S. (2011) · Brain Research · doi:10.1016/j.brainres.2010.09.101 · Cited by 711 · cited 1×
“…and other animal models suggest that autism is accompanied by premature or accelerated neuronal growth early in cortical development, which is followed by normal or reduced sizes in adolescence and adulthood (Casanova, 2007; Chomiak et al., 2010; Courchesne et al., 2011; Chomiak and Hu, 2013).”
BackgroundNeuropathology of Infantile Autism
Kemper, T. L., & Bauman, M. (1998) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199807000-00001 · Cited by 585
A clinical study of 57 children with fetal anticonvulsant syndromes
Moore, S. J., Turnpenny, P., Quinn, A., Glover, S., Lloyd, D. J., Montgomery, T., & Dean, J. C. S. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.7.489 · Cited by 562
Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
Ornoy, A. (2009) · Reproductive Toxicology · doi:10.1016/j.reprotox.2009.02.014 · Cited by 526
Autism in children with congenital rubella
Chess, S. (1971) · Journal of Autism and Childhood Schizophrenia · doi:10.1007/bf01537741 · Cited by 457 · cited 1×
“Examples include maternal rubella infection (Chess, 1971), ethanol (Nanson, 1992), misoprostol (Bandim et al., 2003), thalidomide (Stromland et al., 1994), and valproic acid (VPA; Clayton-Smith and Donnai, 1995; Moore et al., 2000; Ornoy, 2009; Christensen et al., 2013; Roullet et al., 2013).”
BackgroundCharacteristics of fetal anticonvulsant syndrome associated autistic disorder
Rasalam, A., Hailey, H., Williams, J., Moore, S., Turnpenny, P., Lloyd, D., & Dean, J. (2005) · Developmental Medicine & Child Neurology · doi:10.1017/s0012162205001076 · Cited by 456
The intense world syndrome-an alternative hypothesis for autism
Markram, H. (2007) · Frontiers in Neuroscience · doi:10.3389/neuro.01.1.1.006.2007 · Cited by 394 · cited 2×
“…results from embryonic exposure to VPA in the rat (e.g., VPA-rat model; Vorhees, 1987; Rodier et al., 1996; for review see Rodier et al., 1997; Markram et al., 2007), and a VPA-mouse model is also Frontiers in Behavioral Neuroscience www.frontiersin.org July 2013 | Volume 7 | Article 88 |…”
BackgroundMethodInfluentialSelf-citationIngram, J. L., Peckham, S. M., Tisdale, B., & Rodier, P. M. (2000) · Neurotoxicology and Teratology · doi:10.1016/s0892-0362(99)00083-5 · Cited by 381 · cited 2×
“In utero exposure to VPA between 350–800 mg/kg around E11–12.5 seems to be the critical time window for most autistic-like behavioral and anatomical abnormalities in rats and mice (Ingram et al., 2000; Schneider et al., 2001; Schneider and Przewlocki, 2005; Markram et al., 2008; Kim et al., 2011).”
BackgroundInfluentialComorbid anxiety symptoms in children with pervasive developmental disorders
Muris, P., Steerneman, P., Merckelbach, H., Holdrinet, I., & Meesters, C. (1998) · Journal of Anxiety Disorders · doi:10.1016/s0887-6185(98)00022-x · Cited by 368 · cited 2×
“Abnormal high anxiety, fears and phobias are also commonly reported in autism (Kanner, 1943; Muris et al., 1998; however, see Bernier et al., 2005; Evans et al., 2005; Hofvander et al., 2009; Settipani et al., 2012).”
BackgroundSensorimotor gating deficits in adults with autism
Perry, W., Minassian, A., Lopez, B., Maron, L., & Lincoln, A. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.025 · Cited by 352 · cited 1×
“…Stanton et al., 2007; Markram et al., 2008; Bambini-Junior et al., 2011; Kim et al., 2011; Zhang et al., 2012) and commonly found in the autistic spectrum (McAlonan et al., 2002; Gaigg and Bowler, 2007; Perry et al., 2007; Hofvander et al., 2009; MacNeil et al., 2009; van Steensel et al., 2011).”
BackgroundKataoka, S., Takuma, K., Hara, Y., Maeda, Y., Ago, Y., & Matsuda, T. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001714 · Cited by 341 · cited 3×
“While feeding symptoms and restricted diet are consistently reported to differ from controls, that is not case for energy intake which may (Evans et al., 2012) or may not (Emond et al., 2010; Kataoka et al., 2013) differ in ASD (Evans et al., 2012).”
BackgroundFeeding Symptoms, Dietary Patterns, and Growth in Young Children With Autism Spectrum Disorders
Emond, A., Emmett, P., Steer, C., & Golding, J. (2010) · Pediatrics · doi:10.1542/peds.2009-2391 · Cited by 338
Validating γ oscillations and delayed auditory responses as translational biomarkers of autism
Gandal, M. J., Edgar, J. C., Ehrlichman, R. S., Mehta, M., Roberts, T. P. L., & Siegel, S. J. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.09.031 · Cited by 314
Schneider, T., Turczak, J., & Przewłocki, R. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300767 · Cited by 302 · cited 1×
“…lower sensitivity to pain, impaired sensorimotor gating or eye blink conditioning, and increased anxiety described in VPA-treated offspring (Schneider et al., 2001, 2006, 2007; Schneider and Przewlocki, 2005; Stanton et al., 2007; Markram et al., 2008; Bambini-Junior et al., 2011; Kim et…”
BackgroundThe involvement of Reelin in neurodevelopmental disorders
Folsom, T. D., & Fatemi, S. H. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.08.015 · Cited by 275 · cited 2×
“ORIGINAL RESEARCH ARTICLE published: 24 July 2013 doi: 10.3389/fnbeh.2013.00088 General developmental health in the VPA-rat model of autism”
InfluentialKim, K. C., Kim, P., Go, H. S., Choi, C. S., Park, J. H., Kim, H. J., Jeon, S. J., dela Pena, I. C., Han, S., Cheong, J. H., et al. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12147 · Cited by 212
Rinaldi, T. (2008) · Frontiers in Neural Circuits · doi:10.3389/neuro.04.004.2008 · Cited by 210 · cited 1×
“Importantly, broadening and improvement of the diagnostic criteria alone do not explain such an increase (Weintraub, 2011).”
BackgroundDietary Patterns and Body Mass Index in Children with Autism and Typically Developing Children
Evans, E. W., Must, A., Anderson, S. E., Curtin, C., Scampini, R., Maslin, M., & Bandini, L. (2012) · Research in Autism Spectrum Disorders · doi:10.1016/j.rasd.2011.06.014 · Cited by 201 · cited 1×
“While feeding symptoms and restricted diet are consistently reported to differ from controls, that is not case for energy intake which may (Evans et al., 2012) or may not (Emond et al., 2010; Kataoka et al., 2013) differ in ASD (Evans et al., 2012).”
BackgroundHyperconnectivity of Local Neocortical Microcircuitry Induced by Prenatal Exposure to Valproic Acid
Rinaldi, T., Silberberg, G., & Markram, H. (2008) · Cerebral Cortex · doi:10.1093/cercor/bhm117 · Cited by 184
Self-citationBehavior and serotonergic disorders in rats exposed prenatally to valproate: A model for autism
Dufour-Rainfray, D., Vourc’h, P., Le Guisquet, A.-M., Garreau, L., Ternant, D., Bodard, S., Jaumain, E., Gulhan, Z., Belzung, C., Andres, C. R., et al. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2009.12.054 · Cited by 168
A review of the evidence for the canonical Wnt pathway in autism spectrum disorders
Kalkman, H. (2012) · Molecular Autism · doi:10.1186/2040-2392-3-10 · Cited by 142
Converging evidence for brain stem injury in autism
RODIER, P. M. (2002) · Development and Psychopathology · doi:10.1017/s0954579402003085 · Cited by 104 · cited 3×
“…in the first trimester of gestation represents the highest risk for the child to develop autism, in particular after exposure during the time of neural tube closure and genesis of brainstem cranial nerve nuclei cells (Kemper and Bauman, 1998; Rodier, 2002, 2004; Arndt et al., 2005; Ornoy, 2009).”
BackgroundResultVorhees, C. V. (1987) · Psychopharmacology · doi:10.1007/bf00177911 · Cited by 88
Effects of Rat Prenatal Exposure to Valproic Acid on Behaviour and Neuro-Anatomy
Mychasiuk, R., Richards, S., Nakahashi, A., Kolb, B., & Gibb, R. (2012) · Developmental Neuroscience · doi:10.1159/000341786 · Cited by 82
The mouse Engrailed genes: A window into autism
KUEMERLE, B., GULDEN, F., CHEROSKY, N., WILLIAMS, E., & HERRUP, K. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.09.009 · Cited by 60 · cited 1×
“…the oxytocin system (Modi and Young, 2012), the Reelin signaling pathway (Lakatosova and Ostatnikova, 2012; Folsom and Fatemi, 2013), the Wnt canonical pathway (Kalkman, 2012), the engrailed genes (Kuemerle et al., 2007), MeCP2 (Gonzales and LaSalle, 2010) and, neuroligins (Xu et al., 2012).”
BackgroundNew Frontiers in Animal Research of Psychiatric Illness
Kaffman, A., & Krystal, J. J. (2012) · Methods in Molecular Biology · doi:10.1007/978-1-61779-458-2_1 · Cited by 59
Cited by
Zoghbi, H. Y., & Bear, M. F. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009886 · Cited by 797
Melancia, F., Schiavi, S., Servadio, M., Cartocci, V., Campolongo, P., Palmery, M., Pallottini, V., & Trezza, V. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14435 · Cited by 145
Codagnone, M. G., Podestá, M. F., Uccelli, N. A., & Reinés, A. (2015) · Developmental Neuroscience · doi:10.1159/000375489 · Cited by 115
Sabers, A., Bertelsen, F. C. B., Scheel-Krüger, J., Nyengaard, J. R., & Møller, A. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.07.036 · Cited by 43
Raza, S., Harker, A., Richards, S., Kolb, B., & Gibb, R. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.12.055 · Cited by 37
Metadata
- Authors
- Favre, M. R., Barkat, T. R., LaMendola, D., Khazen, G., Markram, H., & Markram, K.
- Venue
- Frontiers in Behavioral Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2013
- Volume
- 7
- Pages
- 88-88
- ISSN
- 1662-5153 (ISSN-L)
- OpenAlex
- W2093870301
- Cited by
- 140
- References
- 33
- FWCI
- 5.05
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.